Kostikas K - Search Results

1

Surfactant Proteins in Smoking-Related Lung Disease.

Papaioannou AI, Papiris S, Papadaki G, Manali ED, Roussou A, Spathis A, Karakitsos P, Kostikas K. Papaioannou AI, et al. Among authors: kostikas k. Curr Top Med Chem. 2016;16(14):1574-81. doi: 10.2174/1568026616666150930120640. Curr Top Med Chem. 2016. PMID: 26420367 Review.

2

BMI and gastroesophageal reflux in women.

Kostikas K, Papaioannou AI, Gourgoulianis KI. Kostikas K, et al. N Engl J Med. 2006 Aug 24;355(8):848; author reply 849-50. doi: 10.1056/NEJMc061773. N Engl J Med. 2006. PMID: 16929003 No abstract available.

3

Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

Papaioannou AI, Kostikas K, Kollia P, Gourgoulianis KI. Papaioannou AI, et al. Among authors: kostikas k. Respir Res. 2006 Oct 17;7(1):128. doi: 10.1186/1465-9921-7-128. Respir Res. 2006. PMID: 17044926 Free PMC article. Review.

4

Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis.

Daniil ZD, Papageorgiou E, Koutsokera A, Kostikas K, Kiropoulos T, Papaioannou AI, Gourgoulianis KI. Daniil ZD, et al. Among authors: kostikas k. Pulm Pharmacol Ther. 2008;21(1):26-31. doi: 10.1016/j.pupt.2006.10.005. Epub 2006 Oct 18. Pulm Pharmacol Ther. 2008. PMID: 17161968

5

Portable exhaled nitric oxide as a screening tool for asthma in young adults during pollen season.

Kostikas K, Papaioannou AI, Tanou K, Koutsokera A, Papala M, Gourgoulianis KI. Kostikas K, et al. Chest. 2008 Apr;133(4):906-13. doi: 10.1378/chest.07-1561. Epub 2007 Oct 20. Chest. 2008. PMID: 17951619 Clinical Trial.

6

Clinical, functional and biochemical changes during recovery from COPD exacerbations.

Koutsokera A, Kiropoulos TS, Nikoulis DJ, Daniil ZD, Tsolaki V, Tanou K, Papaioannou AI, Germenis A, Gourgoulianis KI, Kostikas K. Koutsokera A, et al. Among authors: kostikas k. Respir Med. 2009 Jun;103(6):919-26. doi: 10.1016/j.rmed.2008.12.006. Epub 2009 Jan 4. Respir Med. 2009. PMID: 19121927 Free article.

7

Global assessment of the COPD patient: time to look beyond FEV1?

Papaioannou AI, Loukides S, Gourgoulianis KI, Kostikas K. Papaioannou AI, et al. Among authors: kostikas k. Respir Med. 2009 May;103(5):650-60. doi: 10.1016/j.rmed.2009.01.001. Epub 2009 Jan 24. Respir Med. 2009. PMID: 19167871 Free article. Review.

8

Matrix metalloproteinases in respiratory diseases: from pathogenesis to potential clinical implications.

Oikonomidi S, Kostikas K, Tsilioni I, Tanou K, Gourgoulianis KI, Kiropoulos TS. Oikonomidi S, et al. Among authors: kostikas k. Curr Med Chem. 2009;16(10):1214-28. doi: 10.2174/092986709787846587. Curr Med Chem. 2009. PMID: 19355880 Review.

9

Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis.

Papaioannou AI, Zakynthinos E, Kostikas K, Kiropoulos T, Koutsokera A, Ziogas A, Koutroumpas A, Sakkas L, Gourgoulianis KI, Daniil ZD. Papaioannou AI, et al. Among authors: kostikas k. BMC Pulm Med. 2009 May 9;9:18. doi: 10.1186/1471-2466-9-18. BMC Pulm Med. 2009. PMID: 19426547 Free PMC article.

10

Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?

Hillas G, Loukides S, Kostikas K, Bakakos P. Hillas G, et al. Among authors: kostikas k. Curr Med Chem. 2009;16(22):2824-38. doi: 10.2174/092986709788803178. Curr Med Chem. 2009. PMID: 19689266 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296 results

Search Page

Filters